Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Department of Pathology, Chongqing Medical University, Chongqing, 400016, China.
Cancer Med. 2018 Apr;7(4):1170-1182. doi: 10.1002/cam4.1424. Epub 2018 Mar 13.
In this study, we aimed to compare and validate the prognostic abilities of preoperative systemic immune cells in hepatocellular carcinoma (HCC) after curative hepatectomy. We developed two nomograms to predict the postoperative recurrence-free survival (RFS) and overall survival (OS) after comparisons of the systemic immune cell prognostic scores. The two nomograms were constructed based on 305 patients who underwent curative hepatectomy for HCC. The predictive accuracy and discriminative ability of the nomograms were compared with six commonly used staging systems for HCC. The results were validated using bootstrap resampling and an internal validation cohort of 142 patients and an external validation cohort of 169 patients. Necroinflammatory activity in peritumoral liver tissues in the primary cohort was evaluated by hematoxylin and eosin (H&E) staining. Neutrophil, monocyte, and lymphocyte ratio (NMLR) had a higher area under the receiver operating characteristic curves (AUROC) value at both RFS (AUC = 0.603) and OS (AUC = 0.726) compared to that of other systemic immune cell prognostic scores. The independent predictors of RFS or OS, including α-fetoprotein (AFP), tumor size, tumor number, microvascular invasion, and NMLR, were incorporated into the two nomograms. In the primary cohort, the C-indexes of the RFS and OS nomograms were 0.705 and 0.797, respectively. The ROC analyses showed that the two nomograms had larger AUC values (0.664 for RFS and 0.821 for OS) than those of the American Joint Commission on Cancer seventh edition, Barcelona Clinic Liver Cancer, Cancer of the Liver Italian Program, Japan Integrated Staging Score, Okuda stage, and the Vauthey's system. These results were verified by internal and external validations. The nomogram-predicted probability of RFS was associated with peritumoral necroinflammatory activity scores (r = 0.304, P < 0.001). The proposed nomograms had accurate prognostic prediction in patients with HCC after curative hepatectomy.
在这项研究中,我们旨在比较和验证根治性肝切除术后术前系统性免疫细胞对肝细胞癌 (HCC) 的预后能力。我们通过比较系统性免疫细胞预后评分,开发了两种预测术后无复发生存 (RFS) 和总生存 (OS) 的列线图。这两种列线图是基于 305 名接受 HCC 根治性肝切除术的患者构建的。通过 bootstrap 重采样以及内部验证队列的 142 名患者和外部验证队列的 169 名患者,比较了列线图的预测准确性和区分能力。在原发性队列中,通过苏木精和伊红 (H&E) 染色评估肿瘤周围肝组织的坏死性炎症活动。与其他系统性免疫细胞预后评分相比,中性粒细胞、单核细胞和淋巴细胞比值 (NMLR) 在 RFS(AUC=0.603)和 OS(AUC=0.726) 时具有更高的受试者工作特征曲线 (ROC) 曲线下面积 (AUROC) 值。RFS 或 OS 的独立预测因子,包括甲胎蛋白 (AFP)、肿瘤大小、肿瘤数量、微血管侵犯和 NMLR,被纳入到两个列线图中。在原发性队列中,RFS 和 OS 列线图的 C 指数分别为 0.705 和 0.797。ROC 分析表明,两个列线图的 AUC 值(0.664 用于 RFS 和 0.821 用于 OS)均大于美国癌症联合委员会第七版、巴塞罗那临床肝癌、意大利肝癌计划、日本综合分期评分、Okuda 分期和 Vauthey 系统。内部和外部验证验证了这些结果。列线图预测的 RFS 概率与肿瘤周围坏死性炎症活动评分相关(r=0.304,P<0.001)。该列线图可准确预测根治性肝切除术后 HCC 患者的预后。